NEW YORK (GenomeWeb News) — The synthetic biology company Verdezyne will develop novel genes for Syngenta, which will test them for enzyme expression in plants, Verdezyne said today.

Formerly called Coda Genomics, Verdezyne uses computational algorithms to design and synthesize gene libraries used to make proteins, metabolic pathways, and microorganisms, which are in turn used to make platform chemicals and biofuels.

Syngenta sells genetically modified plant seeds and biology-based crop protection technologies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.